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Ab s tra c t
Cor e-s h ell  n a no p a r ticle s  (CS NPs)  w e r e  d evelop e d  to  g e t  ove r  t h e r a p e u tic
a m o u n t  of  kynu r e nic  a cid  (KYNA)  a c ross  t h e  blood-b r ain  b a r ri e r  (BBB).
Bovine  s e r u m  alb u min  (BSA) w a s  u s e d  a s  co r e  for  e n c a p s ula tion  of KYNA
a n d  t h e  BSA/KYNA  co m posi t e  w e r e  finally  e n c a p s ula t e d  by
poly(allyla min e)  hyd roc hlo rid e  (PAH)  polym e r  a s  s h ell.  In  t h e  in t e r e s t  of
t h e  op timiza tion  of  t h e  syn t h e sis  t h e  BSA  a n d  KYNA  int e r a c tion  w a s
s t u die d  by  t wo-di m e n sion al  s u rf ac e  pl a s mo n  r e son a nc e  (SPR)  t ec h niqu e
a s  w ell.  The  ave r a g e  size  of  d  ~  1 0 0  n m  w a s  p rove n  by  dyn a mic  ligh t
sc a t t e rin g  (DLS)  a n d  t r a n s mission  el ec t ron  mic roscopy  (TEM),  w hile  t h e
s t r u c t u r e  of  t h e  co m posi t e s  w e r e  ch a r ac t e rize d  by  fluor e sc e nc e  (FL)  a n d
ci rcula r  dich rois m  (CD)  s p e c t ro scopy.  The  in  vi tro  r e l e a s e  p rop e r ti es  of
KYNA w e r e  inves tiga t e d  by  a  ve r tic al  diffusion  cell a t  2 5.0  °C a n d  3 7.5  °C
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a n d  t h e  kin e tic  of t h e  r el e a s e  w e r e  disc uss e d .  The  p e n e t r a tion  c a p a ci ty of
t h e  NP s  in to  t h e  ce n t r al  n e rvous  sys t e m  (CNS)  w a s  t e s t e d  by  a n  in  vi tro
BBB  m o d el.  The  r e s ul ts  d e m o ns t r a t e d  t h a t  t h e  e nc a p s ula t e d  KYNA h a d
significa n tly  hig h e r  p e r m e a bili ty  co m p a r e d  to  fre e  KYNA  m olec ule s.  In
t h e  n e u robiological  s e ri al  of  in  vivo  exp e rim e n t s  t h e  effec t s  of
p e riph e r ally  a d minis t e r e d  KYNA with  CS NPs  w e r e  s t u die d  in  co m p a rison
with  u n t r e a t e d  KYNA.  The s e  r e s ul t s  cle a rly  p rove d  t h a t  KYNA  in  t h e
CS NPs,  a d minis t r a t e d  p e riph e r ally  is  s ui t a bl e  to  c ros s  t h e  BBB  a n d  to
ind uc e  el ec t rop hysiological  effec t s  wi thin  t h e  CNS.  As  t h e
n e u ro p ro t ec tive  p ro p e r ti es  of  KYNA  no w a d ays  a r e  p rove n,  t h e
im po r t a n c e  of t h e  r e s ul t s  is obvious.
Key words : kyn u r e nic  a cid,  co r e-s h ell n a nop a r ticles,  r el e a s e ,  r el e a s e  
kine tic, BBB m o d el
Lis t  o f  a b br evia t i o n s
BSA,  bovine  s e r u m  alb u min;  BBB,  blood-b r ain  b a r ri e r ;  CD,  ci rc ul a r
dich rois m;  CNS, c e n t r al  n e rvous  sys t e m;  CS NPs,  co r e-s h ell n a no p a r ticle s;
DLS,  dyn a mic  ligh t  sc a t t e rin g;  FL,  fluor e sc e nc e  s p ec t roscopy;  H PLC-MS,
hig h  p e rfo r m a n c e  liquid  c h ro m a to g r a p hy-m a s s  s p e c t ro m e t ry;  IEP,
isoelec t ric  poin t ,   KYNA,  kynu r e nic  a cid;  L-KYN,  L-kynu r e nin e;  PAH,
poly(allyla min e)  hyd roc hlo ride;  PBS,  p hos p h a t e  b uffe r;  RBECs,  r a t  b r ain
e n do t h elial  c ells;  SEPs,  so m a tos e n so ry  evoke d  r e s po ns e s;  S PR,  s u rfac e
pla s mo n  r e so n a nc e;  TEM,  t r a n s mission  elec t ron  mic roscopy;  Trp,
t ryp top h a n;
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1 . I n tr o d u c t i o n
M a ny  po t e n ti al  t h e r a p e u tic  a g e n t s  t h a t  a r e  u s e d  in  biological  sys t e m s
a r e  limit e d  b e c a u s e  t h ey  c a n’t  g e t  t h ro u g h  t h e  BBB,  t h a nks  to  t h ei r
p ro p e r ti e s,  for  ex a m ple  size,  hyd ro p hilic  c h a r a c t er,  c h a r g e ,  e t c.  This
b a r ri e r  c a n  b e  ci rc u mve n t e d  by  s p e cific  t r a n s po r t e r s ,  c h e mic al
m o difica tions,  in t e r a c tions  wi th  o t h e r  m olec ule s  o r  a p plica tion  of
co m posit e s  (Gab t h uler,  2 0 1 0) .  The  kyn u r e nin e  p a t h w ay  is  t h e  m ain  ro u t e
of  t ryp top h a n  (Trp)  m e t a bolis m  in  m a m m alia n  b r ain,  w hich  involves
s eve r al  n e u ro ac tive  co m po u n d s.  KYNA  is  a  p rod uc t  of  t h e  Trp
m e t a bolis m,  it  h a s  a  n e u ro p ro t ec tive  a n d  n e u roinhibi to ry  p rop e r ti e s
(S to n e,  1 9 9 3;  M a rosi  e t  al .,  2 0 1 0;  S a s  e t  a l.,  2 0 0 7) .  It  ex e r t s  i t s  effec t
m ainly  by  a n t a go nizing  ionot ro pic  glu t a m a t e  r e c e p to r s,  i ts
n e u ro p ro t ec tive  c a p aci ty  c a n  b e  a t t r ib u t e d  m ainly to  t h e  inhibi tion  of  t h e
N-m e t hyl-D-a s p a r t a t e  (N MDA)  r e c e p to r s.  KYNA  c a n  also  influe nc e  t h e
p r e syn a p tic  glu t a m a t e  r el e a s e  by  a n t a go nizing  t h e  7-nicotinic-α
a c tylcholine  r e c e p to r s  (Ca r p e n e do  e t  al.,  2 0 0 1;  Za do ri  e t  a l.,  2 0 0 9) . KYNA
mi g h t  pl ay  impor t a n t  r ole s  in  m o d ula ting  n e u ro t r a n s mission  in  t h e  CNS
(Fuku s hi m a  e t  al.,  2 0 0 7).  Alte r a tions  of  t h e  kyn u r e nin e  m e t a bolit e s  h ave
b e e n  d e m o n s t r a t e d  in  s eve r al  n e u rological  di so r d e r s  s uc h  a s
H u n ting to n’s  di se as e ,  mig r ain e  o r  s t roke  (Da rling to n  e t  al.,  2 0 0 7;  Vécs ei
e t  al .,  2 0 1 3).  Eleva ting  t h e  level  of t h e  n e u rop ro t e c tive  KYNA in  t h e  b r ain
h a s  b e e n  d e m o n s t r a t e d  to  b e  of  t h e r a p e u tic  value  in  a ni m al  m o d els  of
Pa rkinson’s  dis e a s e ,  H u n ting to n’s  dis e a s e  a n d  mig r ain e  (Feje s  e t  a l.,
2 0 1 1;  Silva-Adaya  e t  al.,  2 0 1 1).  H o w ever,  sys t e mic  a d minis t r a tion  of
KYNA is  no t  r e a s on a ble,  b ec a u s e  it s  p e n e t r a tion  t h ro u g h  t h e  BBB is  ve ry
poor.  In  ou r  r e c e n t  s t u die s,  w e  syn t h e size d  a  n e w  co m po u n d,
glucos a min e-kynu r e nic  a cid  (KYNA-N H-GLUC),  w hich  in  p e rip h e r al
a d minis t r a tion  w a s  a bl e  to  c ro ss  t h e  BBB, a n d  to  ind uc e  r e d uc tions  in  t h e
a m pli tud e s  of  t h e  evoke d  r e s pon s e s ,  si mila r  to  t hos e  of  KYNA
a d minis t r a t e d  int r a c e r e b rove n t ricul a rly  (Füvesi  e t  a l.,  2 0 0 4).  Afte r w a r d s,
o t h e r  effec tive  KYNA  d e riva tives  w e r e  syn t h e size d  w hich  w e r e  a bl e  to
c ross  t h e  BBB a n d  to  ind uc e  n e u ro p ro t ec tive  effec t s  in  c a s e  of p e rip h e r al
a d minis t r a tion  too  (Na gy e t  al., 2 0 1 1;  F ülöp  e t  al., 2 0 1 2).
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Applica tion  of  novel,  n a no t e c h nology-b a s e d  c a r ri e r  sys t e m s  m ay
p ro mot e  d r u g  d elive ry  in to  t h e  b r ain,  w hich  m ay  offe r  fut u r e  t h e r a p e u tic
op tions  for  s eve r al  n e u rological  diso rd e r s .  Diffe r e n t  n a noc a r rie r  sys t e m s
h ave  b e e n  d evelop e d  a n d  e a rly  in  vi tro  a n d  p r e clinic al  s t u die s  yield e d
p ro mising  r e s ul t s  to  a c hieve  d r u g  d elive ry  t h ro u g h  t h e  BBB (Wong  e t  al .,
2 0 1 2;  Lu  e t  al.,  2 0 1 4).  N ow a d ays,  t h e  a p plica tion  of  CS NPs  h a s  b e co m e
a n  a r e a  of  in t e n s e  g rowing  int e r e s t .  The  alb u min-b a s e d  NP s  a r e
conside r e d  to  b e  a t t r a c tive  oppo r t u ni ty  a s  c a r ri e r  sys t e m s  b ec a u s e  m a ny
binding  si t e s  a r e  r e a c h a ble  to  va rious  d r u g  m olec ules .  The  alb u mins  h ave
s eve r al  s p ecific  a dv a n t a g e s  in  n a no-sc ale  r a n g e,  s uc h  a s  biod e g r a d a bility,
bioco m p a tibili ty  a n d  no n-toxici ty  (Elzog h by  e t  al.,  2 0 1 2)  so  t h e  BSA  is
wid ely  u s e d  for  d r u g  d elive ry,  u sin g  c a r ri e r s  s uc h  a s  mic rop a r ticles,
n a nos p h e r e s ,  NPs  a n d  g el s  (Wan g  e t  al.,  2 0 0 8).  The  s eco n d a ry  s t r uc t u r e
of t h e  BSA c a n  b e  exa min e d  by  CD s p e c t ro scopy sinc e  it  h a s  t wo  n e g a tive
b a n d s  (208  n m,  2 2 2  n m)  in  t h e  fa r  UV  r e gion;  t h e  fi rs t  b a n d  is
ch a r ac t e ri s tic  for  α-h elical  s t r uc t u r e  of  t h e  p ro t ein  (Kelly  e t  a l.,  2 0 0 5)
w hich  c a n  b e  c alcula t e d  fro m  t h e  obs e rve d  ellip tici ty  valu es  (M a n d al  e t
al .,  2 0 1 0).  To e n c a p s ula tion  of diffe r e n t  m olec ule s  fre q u e n tly polym e r s  o r
polyelec t rolyt e s,  s uc h  t h e  poly(lac tic-co -glycolicacid  (PLGA) (Rafa ti  e t  al .,
2 0 1 2),  polye t hylen e  glycol (PEG) (Ashja ri  e t  a l.,  2 0 1 2) ,  chi tos a n  (Bow m a n
e t  al.,  2 0 0 6)  o r  t h e  PAH  a r e  u s e d .  The  PAH  is  a  syn t h e tic  c a tionic
polyelec t rolyt e  w hich  is  w a t e r-soluble  a n d  biod e g r a d a ble,  so  it  u s e d  in
n a no t ec h nology a n d  n a no m e dic al  field  a s  w ell (Zhou  e t  al.,  2 0 0 4 ; Wyt rw al
e t  al.,  2 0 1 4) . 
In  t his  s t u dy,  BSA-b a s e d  CS NPs  w e r e  d evelop e d  for  KYNA
e n c a p s ula tion.  Size  a n d  s t r uc t u r al  info r m a tion  w e r e  g ain e d  by  DLS,  TEM
a n d  CD  m e t ho ds.  In  vi tro  m e a s u r e m e n t s  w e r e  p e rfo r m e d  to  s t u dy  t h e
r el e a s e  p ro p e r ti e s  a n d  t h e  r el e a s e  m e c h a nis m  of  t h e  KYNA.  An  in  vi tro
BBB  m o d el  w a s  a p plied  to  a s s e s s  t h e  p e n e t r a tion  c a p a ci ty  of  t h e
e n c a p s ula t e d  KYNA  co m p a r e d  to  fre e  KYNA.  In  t h e  in  vivo
n e u ro p hysiological  s t u die s,  t h e  effec t s  of  in t r a p e ri ton e ally  (i.p.)
a d minis t e r e d  KYNA,  it s  p ro d r u g  L -kyn u r e nin e  (L -KYN),  BSA/PAH  a n d
BSA/KYNA/PAH w e r e  s t u die d.
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2 . M a t er i a l s  a n d  M e t h o d s
2.1.  M a t erials
The  BSA (fr ac tion  V),  t h e  KYNA, t h e  PAH  wi th  M W of  1 5.0 0 0  g  m ol -1 ,  t h e
co m po n e n t s  of t h e  p hos p h a t e  b uffe r  (PBS),  t h e  sodiu m  p hos p h a t e  dib a sic
h exa d ec a hyd r a t e  (N a 2H PO 4  × 1 6 H 2O)  a n d  t h e  sodiu m  p hos p h a t e
m o nob a sic  m o no hyd r a t e  (N a H 2PO 4  ×  H 2O)  w e r e  p u rc h a s e d  fro m  Sig m a
Aldrich.  The  sodiu m  c hlo ride  (N aCl)  a n d  t h e  so diu m  hyd roxide  (N aO H)
p a s tilles  w a s  bou g h t  fro m  Mola r  Ch e mic als.  Hig hly  p u rified  w a t e r  w a s
ob t ain e d  by  d eioniza tion  a n d  fil t r a tion  wi t h  a  Millipo r e  p u rifica tion
a p p a r a t u s .  All solven t s  a n d  r e a g e n t s  u s e d  w e r e  of a n aly tic al g r a d e  a n d  no
fur t h e r  p u rifica tions  w e r e  m a d e .  
2.2.  S y n t h e sis  of  C S NPs   
All  s a m ples  w e r e  p r e p a r e d  in  PBS  b uffe r  (pH  =  7.4)  a t  2 5.0  °C  with
cons t a n t  ionic  s t r e n g t h  (0.9  %  w/v  N aCl).  The  BSA (6  %  w/v)  w a s  s ti r r e d
in  PBS,  af t e r  fully  dissolving  9 0  m g  KYNA  w a s  a d d e d  to  t h e  p ro t ein
solu tion  (BSA :  KYNA m ola r  r a tio  is  1  :  1 7 5).  The  BSA/KYNA co m posit e
disp e r sion  w a s  s ti r r e d  for  t wo  ho u r s .  The n  PAH solu tion  (0.24  % w/v; PBS,
p H  =  7.4)  w a s  a d d e d  to  t h e  BSA/KYNA co m posit e .  The  final  volu m e  w a s  3
ml.  The  p ro d uc t s  w e r e  s to r e d  a t  -8 0  °C  b ec a u s e  of  t h e  s t a bili ty  of  t h e
d r u g  a n d  t h e  p ro t ein  m olec ule s.  
2.3.  M a t erials  c harac t eri za tion
For  d e t e r min a tion  of  t h e  c h a r g e  of  t h e  ini ti al  m a t e ri als  (BSA, PAH) a t  p H
=  7.4  t h e  co m po n e n t s  w e r e  ti t r a t e d  wit h  N a O H  (c N aO H  =  1.0  M)  u sing
p a r ticle  c h a r g e  d e t e c to r  (PCD-0 4  M ÜTEK).  Mo r eover,  t h e  BSA  a n d  t h e
BSA/PAH  co m posit e  w e r e  ti t r a t e d  wi t h  KYNA  to  d efine  t h e  a m o u n t  of
d r u g  m olec ules  in  t h e  in t e r e s t  of  t h e  c h a r g e  co m p e n s a tion.  The
fluo r e sc e n c e  s p ec t r a  w e r e  r e co r d e d  by  a  H o rib a  Jobin  Yvon  Fluo ro m ax-4
s p ec t rofluo ro m e t e r  (excit a tion  a t  2 8 0  n m).  The  size  of  t h e  p r e p a r e d
p ro d uc t s  w e r e  d e t e r min e d  by  DLS  m e t ho d  wi th  a  Ho rib a  SZ-1 0 0
a p p a r a t u s .  Circula r  Dich rois m  (CD)  s p e c t r a  w e r e  r e co r d e d  (190-2 5 0  n m;
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2 5.0  °C; b a n d wid t h:  2  n m;  sc a n ning  s p e e d:  1 0 0  n m/ min)  u sin g  a  Jasco  J-
8 1 5  CD  s p e c t ro m e t e r .  Du ring  t h e  syn t h e sis  fo r  con t rolling  t h e
conc e n t r a tion  of  t h e  KYNA  s p ec t ro p ho to m e t ric  m e a s u r e m e n t s  w e r e
c a r ri e d  ou t  u sing  a  UV–1800  (Shi m a dzu)  s p ec t ro p ho to m e t e r  (a t  3 3 3  n m).
The  TEM  im a g e s  w e r e  r e gi s t e r e d  by  u sing  a  F EI  Tecn ai  G 2 2 0  X-TWIN
mic roscop e  (tun gs t e n  c a t ho d e;  2 0 0  kV).  Th e  SPR  t ec h niq u e  a r e  c a p a ble
of  r e al-tim e  m o ni to rin g  of  bio molec ula r  in t e r a c tions  on  a  gold  s e n so r
s u rf ac e  wit ho u t  t h e  u s e  of  lab els  (Ho mola  e t  a l.  2 0 0 8) .  During  SPR
m e a s u r e m e n t s,  on e  of  t h e  in t e r a c t a n t s  is  im mobilized  fro m  solu tion  on to
a  solid/liquid  in t e rfac e ,  a n d  a  solu tion  of  t h e  o th e r  in t e r a c t a n t  is  p a s s e d
ove r  t h e  func tion alized  gold  s u rf ac e .  During  t his  p roc e d u r e ,  t h e  r ef r ac tive
ind ex a t  t h e  in t e rf ac e  u n d e r go e s  c h a n g e ,  t his  b ein g  di r ec tly r ela t e d  to  t h e
pla s mo n  s hift  ( ) a s  w ell a s  t h e  a m o u n t  of t h e  bio molec ule s  (mΔλ s/
 
n g  c m -2)
a d so r b e d  on  t h e  s u rfac e  of  t h e  bios e n so r  c hip.  Mo r e  d e t ailed  info r m a tion
of  SPR  t ec h niq u e  (m e a s u rin g  p rinciples ,  a p plied  e q u a tions  for
c alcula tions)  s e e  in  Ho mola  e t  a l.,  2 0 0 8  a n d  in  ou r  r e c e n t  p u blica tions
(S e b k  e t  al.,  2 0 1 3;  Cs a pó  e t  al.,  2 0 1 4;  Cs a pó  e t  al .,  2 0 1 5).  ő S PR
m e a s u r e m e n t s  w e r e  c a r ri ed  ou t  on  t h e  t wo-c h a n n el  SPR  s e nso r  pl a tfo r m
d evelope d  a t  t h e  Ins ti t u t e  of  P ho tonics  a n d  Elec t ro nics  (P r a g u e).  The
in t e r a c tion  of  KYNA with  BSA w a s  s t u die d  in  t h e  conc e n t r a tion  r a n g e  of
0.1  – 6.0  m M  in PBS (flow r a t e:  2 5  µL min -1; 1 5 0  m M  N aCl, p H  =  7.4,  2 5.0
°C).  Pa r allel  m e a s u r e m e n t s  h ave  b e e n  p e rfo r m e d  a n d  t h e  s t a n d a r d
d evia tions  of  t h e  so r p tion  exp e ri m e n t s  w e r e  ±  4.5  %.  In  e a c h  s t e p s  8 0 0-
8 0 0  l p ro t ein  a n d  KYNA solu tions  w e r e  injec t e d  a n d  t h e  so r p tion  ti m e  ( ~μ
2 5  mi n)  w a s  follow e d  by  rin sing  p roc e d u r e  u sin g  b uffe r  solu tion.  The
s e nso r g r a m s  (  vs.  tim e)  w e r e  a n alyzed  in  r e al-tim e  by  a  s p e cialΔλ
softw a r e  p a ck a g e  t h a t  allows  d e t e r min a tion  of  t h e  r e so n a n t  w avele n g t h
in bo t h  s e n sin g  c h a n n els.  
2.4.  In  vi tro dr u g  releas e  e x p eri m e n t s
The  in  vi tro  exp e ri m e n t s  w e r e  c a r ri e d  ou t  a cco r din g  to  t h e  p roc e d u r e  d e -
sc rib e d  e a rli e r  (Varg a  e t  al.,  2 0 1 4,  2 0 1 5) . Briefly, t h e  n a nop a r ticle  di sp e r -
sion  co n t aining  KYNA  in  PBS,  (pH  =  7.4)  w a s  s e p a r a t e d  by  c ellulose
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m e m b r a n e  fro m  t h e  p hysiological  solu tion  in  a  ve r tic al  diffusion  c ell
(F r a nz  c ell;  HANSO N  CO.).  The  c ell  w a s  con n ec t e d  to  a  UV-1 8 0 0  s p e c -
t ro p ho to m e t e r  via  a  p e ris t al tic  p u m p  for ming  a  clos e  ci rcul a ting  sys t e m.
The  solu tion  w a s  s ti r r e d  con tinuo usly  wi th  a  h elical  m a g n e tic  s ti r r e r  a n d
t h e  r el e a s e  exp e ri m e n t s  w e r e  c a r ri e d  ou t  a t  2 5 .0  °C  a n d  3 7.5  °C  a s  w ell .
S a m ples  w e r e  t ak e n  eve ry  1 0  min u t e s  d u ring  t h e  fi r s t  ho ur,  a n d  t h e n  only
onc e  eve ry  ho ur.  M e a s u r e m e n t s  w e r e  p e rfo r m e d  in  5 0 0  min u t e s.  The  ex -
p e ri m e n t  w a s  r e p e a t e d  t wo  tim e s  a n d  t h e  s t a n d a r d  d evia tion  of t h e  exp e r -
im e n t s  w a s  ±  2.5%.  
2.5.  Cell cul ture  and  p er m ea bili ty  as say
P ri m a ry  r a t  b r ain  e n do t h elial  c ells  (RBECs),  p e ricyt e s  a n d  glial  c ells  w e r e
isola t e d  a s  d e s c ribe d  p r eviously  (Wilhelm  e t  al.,  2 0 1 1) .  The  in  vi tro  BBB
m o d el  w a s  cons t r u c t e d  by  pl a ting  p e ricyt e s  on to  t h e  b a cksid e  of  1 2-w ell
Tra n s w ell filt e r s  (por e  size:  0 .4  m) a n d  RBECs  on to  t h e  u p p e r  sid e.  Afte rμ
r e a c hing  conflue nc e ,  t h e  e n do t h elial  m o nolaye r  w a s  s u p plied  wi th  5 5 0
n M  hyd roco r tison e,  2 5 0  M  CPT-cAMP  (Sig m a-Aldrich),  a n d  1 7.5  M  RO-μ μ
2 0 1 7 2 4  (Roch e)  a n d  pl ac e d  in to  t h e  CellZscop e  ins t r u m e n t
(na noAnalytics,  M u e n s t er,  Ge r m a ny)  con t aining  glial-con di tione d  m e di a.
TEER  (t r a n s e n do t h elial  el ec t ric al  r e sis t a nc e)  w a s  followe d  u n til  r e a c hing
pla t e a u  of  1 2 0-1 4 0  Oh m  ×  c m 2.  Tr a n s w ell  fil te r s  con t ainin g  e n do t h elial
cells  a n d  p e ricyt e s  w e r e  r e m ove d  fro m  t h e  CellZscop e  ins t r u m e n t.  Fil t e r s
w e r e  w a s h e d  wi th  Ring e r-H EPE S  solu tion  (pH  =  7.4).  Tes t  s u bs t a n c e s
(KYNA o r  BSA/KYNA/PAH)  w e r e  di ssolve d  in  Ring e r-H E PE S  a n d  a p plied
in  t h e  u p p e r  co m p a r t m e n t  in  a  final  conc e n t r a tion  of  2 0  µ M  KYNA.  The
low e r  co m p a r t m e n t  w a s  loa d e d  wi th  Ring e r-H EPES.  S a m ple s  w e r e  t ak e n
fro m  t h e  b a sola t e r al  side  af t e r  1  h.  The  conc e n t r a tions  of  t h e  s a m ples
w e r e  q u a n ti t a t e d  wi th  a n  Agilen t  1 1 0 0  H PLC-M S  sys t e m  (Agilen t
Technologies ,  S a n t a  Cla r a ,  CA, USA).  Pe r m e a bili ty  of  t h e  t e s t  s u bs t a n c es
w a s  c alcula t e d  a s  d e s c rib e d  p r eviously (N a gyoszi  e t  a l.,  2 0 1 0).  S t a tis tical
a n alysis  w a s  p e rfo r m e d  u sing  S t u d e n t’s t-t e s t .  
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2.6.  In  vivo e x p eri m e n t s
2.6.1.  Anim als,  s u r g e ry  a n d  el ec t ro p hysiology
In  vivo  exp e rim e n t s  w e r e  p e rfo r m e d  on  a d ul t  Wis t a r  r a t s ,  w eig hing  3 0 0  g
(n  =  3 0).  Food  a n d  w a t e r  w e r e  av ailable  a d  libi tu m.  All p roc e d u r e s  w e r e
a p p rove d  by  t h e  Anim al  Ca r e  Co m mit t e e  of  t h e  U nive rsi ty  a n d  w e r e
con d uc t e d  a c co r din g  to  t h e  r e co m m e n d a tions  of  t h e  Decla r a tion  of
H elsinki  a n d  Tokyo.  The  a ni m als  w e r e  a n e s t h e tize d  wi t h  a n
in t r a p e ri ton e al  u r e t h a n e  injec tion  (1.3  g  /  kg  bo dy  w eigh t).  Body
t e m p e r a t u r e  w a s  m ai n t ain e d  a t  3 7  ±  0.5  °C  t h ro u g h  t h e  u s e  of  a  s elf-
r e g ula ting  h e a t ing  p a d.  The  so m a tos e n so ry  evoke d  r e s po ns e s  (SEPs)
w e r e  ind uc e d  by  t h e  el ec t ric  s tim ula tion  of  t h e  w hiske r s  wi th  bipola r
n e e dle  el ec t rod e s  (3  - 3 .5  V; 0.2  m s ,  0 . 1  Hz).  Mo r e  d e t ails  of  s u r g e ry  a n d
elec t rop hysiology s e e  in for m e r  wo rks  (Toldi e t  a l., 1 9 8 8,  1 9 9 4).
2.6.2.  Exp e ri m e n t al  g ro u ps  a n d  t r e a t m e n t
KYNA,  L-KYN  (Sig m a-Aldrich,  S t.  Louis,  MO,  U SA),  e nc a p s ula t e d  KYNA,
e m p ty  BSA co m posi t e  a n d  s aline  (n  =  5,  5 ,  6 ,  9 ,  5)  w a s  a d minis t e r e d  via
i.p.  injec tion  af t e r  3 0  min  con t rol p e riod  of t h e  r e co r din gs  (dos e:  3 0 0  m g  /
kg;  s p e e d:  3 3 3  µl  min -1;  p H  =  7.4)  wi t h  t h e  aid  of  a  mic roinjec tion  p u m p
(CMA / 1 0 0,  CMA Mic rodialysis  AB, Kis t a ,  S w e d e n). 
2 .6.3.  S t a tis tic al a n alysis
Rep e a t e d  m e a s u r e m e n t s  of  SER  a m plitu d e s  of  t h e  con t rol  a n d  t r e a t e d
g ro u ps  w e r e  co m p a r e d  s e p a r a t ely  wi th  t h e  aid  of  t h e  no n-p a r a m e t ric
Rela t e d-S a m ples  F rie d m a n’s Two-Way Analysis  of Varia nc e  by R a nks.
3 .  R e s u l t s  a n d  Di s c u s s i o n
In  o r d e r  to  d e sign  diffe r e n t  p ro t ein-b a s e d  n a noc a r rie r  co m posit e
sys t e m s  con t aining  effec tive  d r u g  m olec ule s  t h e  s t u dy  of  t h e  int e r a c tion
b e t w e e n  t h e  p ro t ein  a n d  t h e  d r u g  a g e n t  a s  w ell  a s  t h e  d e t e r min a tion  of
t h e  bin ding  c a p a ci ty  of  p ro t ein  tow a r d s  t h e  d r u g  m olecule  a r e  c r ucial.
Accordingly, t wo-di m e n sion al S PR m e a s u r e m e n t s  w e r e  c a r ri ed  ou t  a t  2 5.0
°C. Fi r s tly t h e  s t u die d  p ro t ein  w a s  im mo bilized  on to  t h e  gold  s u rf ac e  fro m
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a q u e o us  solu tion  (c  =  0.05  m M).  The  r e gi s t e r e d  SPR  s e n so r g r a m  is
p r e s e n t e d  in  Fi g .  1  (A) .  The  gold  s u rf ac e  w as  func tion alize d  wi th  t h e
BSA  in  t wo  s t e p s.  As  t h e  r e gis t e r e d  s e n so r g r a m  s how s  8 1.5  %  of
a d so r b e d  BSA  r e m ains  i r r eve r sibly  bo u n d  a t  gold  s u rfac e  af t e r  r i nsing
p roc e d u r e .  The  binding  of  BSA  on  gold  s u rfac e  c a u s e d   =  5.5  n mΔλ
pla s mo n  s hift  (se e  in  Fi g .  1  (A)  ins e t)  w hich  co r r e s pon ds  to  t h e  m s =
1 4 0.05  n g  c m -2  a d so r b e d  a m o u n t  of  BSA (conve r sion  p u blish e d  in  S e b kő
e t  al.,  2 0 1 3,  H o mola  e t  al .,  2 0 0 8,  Lied b e r g  e t  al.,  1 9 9 3 ).1  Bas e d  on  t h e
r e s ul t s  of  S PR  t h e  a d so r b e d  a m o u n t  (m s /  n g  c m -2),  t h e  a d so r p tion
c a p a city  a t  t h e  m axim al  conc e n t r a tion  (Γm  /  n m ol  c m -2)  a n d  t h e  c ross
s ec tion al  a r e a  (a m  /  n m 2)  of  t h e  s t u die d  p ro t ein  w e r e  d e t e r min e d.  I t  w a s
foun d  t h a t  t h e  Γm  =  0.00 2 1 2 2  n m ol  c m -2  w hile  t h e  c ro ss  s ec tion al  a r e a  of
BSA is  a m  =  7 8.0  n m 2  on  gold  s u rfac e  u n d e r  t h e  a p plied  con di tions  (a m  =
0.16 6  ×  1/  Γm).  In  o r d e r  to  d e t e r min e  t h e  bin ding  c a p a ci ty  of  KYNA on
BSA-cove r e d  gold  s u rf ac e  t h e  so r p tion  of  KYNA on  p ro t ein-func tion alized
bios e n so r  c hip  w a s  inves tig a t e d  a t  2 5 .0  °C  in  t h e  conc e n t r a tion  r a n g e  of
0.1  – 6.0  m M.  The  Fi g .  1  ( B )  indic a t e s  t h a t  inc r e a s e  in  conc e n t r a tion  of
KYNA  solu tions  r e s ul t s  in  high e r  w avele n g t h  s hift  fro m  ~  0.03  n m  to
al mos t  0 .65  n m  (s e e  Fi g .  1  ( B )  s econ d a ry  y-axe s).  The  s e n so r g r a m s  al so
confi r m  t h a t  t h e  in t e r ac tion  b e t w e e n  t h e  KYNA d r u g  m olec ule s  a n d  t his
p ro t ein  is  fully r eve r sible  b e c a u s e  all t h e  a d so r b e d  m a s s  of KYNA r e d u c e d
to  n e a rly  ze ro  af t e r  r in sing  p roc e d u r e s.  This  r eve r sible  in t e r a c tion  is
c r ucial  in  o r d e r  to  d e sig n  po t e n t  n a noc a r ri e r  co m posi t e  sys t e m  for
(con t rolled)  d r u g  d elive ry.  In  t h e  in t e r e s t  of  t h e  d evelop m e n t  of  a n
effec tive  d r u g  d elive ry  sys t e m s  t h e  in t e r a c tion  b e t w e e n  t h e  d r u g  a n d  t h e
c a r ri e r  s hould  b e  s t ro n g  e no u g h  to  facili t a t e  t h e  t r a n s po r t  b u t  al so  w e a k
e no u g h  to  r el e a s e  t h e  d r u g  to  t h e  t a r g e t .  
Pa r ticle s  ch a r g e  d e t e c to r  w a s  u s e d  to  d e t e r min e  t h e  ch a r g e  of  t h e
ini tial  m a t e ri als  a s  a  func tion  of  p H.  Ou r  r e s ul t s  confi r m  t h a t  bo t h  t h e
BSA  a n d  t h e  PAH  a r e  n e g a tively  c h a r g e d  a t  p H  =  7.4.  The  isoelec t ric
poin t  (IEP)  of  BSA a n d  PAH  a r e  4.53  a n d  5.42,  r e s p ec tively  (Fi g .  2  (A) ).
1
 m s =  ×[(Sδλ b/Lp) ×(  n/ c)]δ δ -1× 2 ,  w h e r e  δλ  is  t h e  w av elen g t h( plas mo n) s hift,  S b  is t h e  
b ulk s e n si tivity,
 
L p  is  t h e  SP  p e n e t r a tion  d e p t h,  n/ c  is t h e  co nc e n t r a tion  d e p e n d e n c e  of δ δ
t h e  r ef r ac tive  ind ex, Lied b e r g  e t  al., 1 9 9 3)
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Hyd ro g e n  bo n ds,  hyd ro p ho bic  a n d  al so  -  in t e r ac tions  c a n  d evelopπ π
b e t w e e n  t h e  t wo  m a t e ri als  a t  p hysiologic al  p H,  u nlike  el ec t ros t a tic
in t e r a c tions.  F u r t h e r m o r e ,  t h e  BSA  a n d  t h e  BSA/PAH  co m posi t e  w e r e
ti t r a t e d  wit h  d r u g  m olec ule s  (Fi g .  2  ( B ) ) in  o r d e r  to  d efine  t h e  a m o u n t  of
KYNA in t h e  in t e r e s t  of t h e  ch a r g e  co m p e n s a tion.  Bas e d  on  c alcula tions  it
w a s  e s t a blish e d  t h a t  m  =  4 1 0  a n d  m  =  4 2 5  m g  of  KYNA is  n ec e s s a ry  to
r e a c h  t h e  c h a r g e  co m p e n s a tion  for  1  g  of BSA a n d  BSA/PAH, r e s p ec tively.
Durin g  t h e  syn t h e sis  w e  u s e d  1.22- a n d  1.18- fold exc es s ,  r e s p ec tively. 
DLS  r e s ul t s  (Fi g .  3  (A) )  cle a rly  confi r m e d  t h e  n a no m e t e r  size
r a n g e  of  t h e  p r e p a r e d  p a r ticle s.  I t  w a s  foun d  t h a t  t h e  size  of  t h e
n e g a tively  c h a r g e d  BSA is  a bo u t  d  =  3.8  ±  0.3  n m  a t  p H  =  7.4.  The  size
of  t h e  p ro t ein  did  no t  c h a n g e  significa n tly  by  a d din g  d r u g  m olec ule s
(BSA/KYNA co m posi t e ,  d  =  3.6  ±  0.1  n m). Wh e n  t h e  polyelec t rolyt e s  h ave
bo u n d  to  t h e  BSA in  t h e  a b s e n c e  of  KYNA, t h e  size  inc r e a s e d  to  only  d  =
2 0.5  ±  1.2  n m.  The  bin ding  of KYNA to  t h e  BSA/PAH co m posi t e  facili t a t e s
t h e  bindin g  of  m o r e  polyelec t rolyt e  w hich  r e s ul t s  in  t h e  for m a tion  of  t h e
CS NPs.  The  BSA/KYNA/PAH  co m posi t e s  h ave  a n  ave r a g e  size  of  d  =
1 0 3.4  ±  4.8  n m.  The  r e gis t e r e d  TEM  im a g e  s hows  t h a t  t h e
BSA/KYNA/PAH  CS NPs  h ave  s p h e ric al  s t r u c t u r e  a n d  t h e  c alcula t e d
ave r a g e  dia m e t e r  (d  =  1 1 0  ±  3.5  n m)  is  in  good  a g r e e m e n t  wi t h  t h e  DLS
exp e rim e n t s  a s  w ell (Fi g .  3  ( B ) ). 
The  fluor e sc e nc e  s p ec t r a  of t h e  ini ti al  m a t e ri als  a n d  t h e  co m posi t e s
a r e  s how n  in Fi g .  4 . The  BSA h a s  in t e nsive  e mission  p e a ks  a t   =  3 4 8  n mλ
u sin g  2 8 0  n m  excit a tion.  This  high  valu e  (348  n m)  indic a t e s  t h a t  t h e
t ryp top h a n  r e sid u e  (Trp-1 3 4)  is  in  con t a c t  wi th  bo u n d  w a t e r  m olec ules
(Filenko  e t  al.,  2 0 0 1).  As  Fi g .  4  (A)  s how s,  t h e  con tinuou s  a d di tion  of
KYNA  to  t h e  p ro t ein  c a u s e s  t h e  d e c r e a s e  a n d  al so  t h e  s hift  of  t h e
e mission  p e ak  a t   =  3 4 8  n m  w hic h  co r r e s po n d s  to  t h e  ch a n g e s  of  t h eλ
pola ri ty  a ro u n d  t h e  c h ro mo p ho r e  m olec ule.  This  r e d  s hif t  a l so  indic a t e s
t h a t  Trp  m olec ule s  a r e  m o r e  expos e d  to  t h e  solve n t  on  ave r a g e  (Klajn e r t
e t  a l.,  2 0 0 3 ).  By  a d ding  1 0  m M  KYNA to  t h e  BSA (in  t his  c a s e  t h e  BSA :
KYNA  m ola r  r a tio  is  ca .  1 :13 3),  t h e  e mission  p e ak  of  BSA  is  to t ally
dis a p p e a r e d  a n d  only  t h e  e mis sion  p e a k  a t  3 8 3  n m  a r e  obs e rve d  w hic h
1 0
co r r e s po n d s  to  t h e  e mis sion  of  p u r e  KYNA (Fi g .  4  ( B ) ).   Bas e d  on  t h e
fluo r e sc e n c e  r e s ul t s  high  KYNA  exc es s  (1:175)  w a s  u s e d  for  syn t h e s es .
The  a d di tion  of  polyelec t rolyt e  (which  do e s  no t  t r igg e r  fluor e s c e nc e  a t
t hi s  exci t a tion  w av ele n g t h)  to  t h e  BSA/KYNA n a noco m posi t e  c a us e d  t h e
d e c r e a s e  in t h e  in t e nsi ty of t h e  e mission  p e ak  a t  3 8 3  n m.  This obs e rva tion
p ro b a bly  confi r m  t h e  e nc a p s ula tion  of  BSA/KYNA  p rod uc t  by  t h e  PAH
polym er.  I t  w a s  also  obs e rve d  t h a t ,  in  t h e  a b s e n c e  of  KYNA t h e  e mission
in t e n si ty  of  t h e  BSA  is  significa n tly  inc r e a s e d  by  a d ding  PAH  to  t h e
p ro t ein  (Fi g .  4  ( B ) ,  cu rve  e )  w hic h  s u p po r t  t h e  u nfolding  of  t h e  BSA
ch ains .  
CD is a  ve ry  s e n si tive  m e t ho d  to  m o ni to r  t h e  confo r m a tion al  c h a n g e
in  t h e  p ro t ein’s  s e con d a ry  s t r uc t u r e  (Pe n g  e t  al .,  2 0 1 1 ).  The  s p e c t r a  of
t h e  BSA a n d  t h e  CS NPs  bo t h  in  t h e  p r e s e n c e  a n d  in  t h e  a b s e n c e  of  t h e
KYNA a r e  s how n  in  Fi g .  5 .   The  s p e c t r a  of  t h e  s a m ples  s how  n e g a tive
b a n d s  loca t e d  a t  a ro u n d  2 0 8  n m  a n d  2 2 8  n m.  For  p u r e  BSA  solu tion  a
b a n d  a t  2 2 8  n m  is c h a r a c t e ris tic, t h e  a p p e a r a nc e  of t h e  o t h e r  b a n d  a t  2 0 8
n m  is  no t  do min a n t .  The  a d di tion  of  PAH  o r  KYNA to  t h e  p ro t ein  r e s ul t s
a n  in t e n sive  r e d uc tion  a n d  dis a p p e a r a nc e  of  t his  n e g a tive  b a n d  a t  2 2 8
n m,  r e s p e c tively.  Thes e  r e s ul t s  indic a t e  t h e  binding  of  KYNA  or  t h e
polyelec t rolyt e  to  t h e  BSA.  Mos t  p ro b a bly  t h e  BSA  u n d e r go e s
confor m a tion al  ch a n g e;  t h e  a m o u n t  of  α-h elical  con t e n t  is  sig nifican tly
d e c r e a s e d.  Bas e d  on  t h e  e q u a tion  w hich  w a s  u s e d  for  c alcula tion  (Ma n d al
e t  al .,  2 0 1 0)  t h e  BSA con t ain s  5 3.3  %  of  α-h elical  u ni t s  a t  p H  =  7.4.  This
valu e  is  n e a rly  t h e  s a m e  for  BSA/KYNA  sys t e m  (51.8  %),  b u t  t h e
polyelec t rolyt e  c a u s es  significa n t  p e r t u r b a tion  in  t h e  s t r uc t u r e  of
BSA/KYNA co m posi t e;  it  r e d u c e s  t h e  a m o u n t  of  α-h elical  con t e n t  to  1 5.9
%.  The  PAH  (in  i t s elf)  did  no t  c a u s e  significa n t  d e c r e a s e  in  t h e  α-h elical
con t e n t  (BSA/PAH =  2 9.6  %).  
In  vi tro  r e l e a s e  m e a s u r e m e n t s  w e r e  c a r ri e d  ou t  ove r  a  p e riod  of
5 0 0  mi n  (Fi g .  6 ,  ins e t s).  The  KYNA is  u n s t a ble  in  solu tion:  a t  2 5.0  °C  (A)
a n d  3 7.5  °C  (B)  t h e  “pu r e”  KYNA  d e co m pos e s  wi thin  2  ho u r s  w hich  is
d el aye d  by  a p plica tion  of  co m posi t e s.  The  r el e a s e  r a t e  is  5 5  %  af t e r  5 0 0
mi n u t e s  in  t h e  c a s e  of  bo t h  BSA/KYNA  a n d  t h e  BSA/KYNA/PAH
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co m posit e s  a t  2 5.0  °C.  At  high e r  t e m p e r a t u r e ,  t h e  d e co m posi tion  of  t h e
KYNA is  fas t er,  significa n t  d e c r e a s e  w a s  obs e rve d  in  t h e  conc e n t r a tion  of
t h e  KYNA af t e r  5 0 0  min.   If w e  s t u dy t h e  fir s t  ho u r  it  c a n  b e  s e e n  t h a t  t h e
a m o u n t  of  KYNA  dis solving  fro m  t h e  CS NPs  (23  %  a t  2 5.0  °C)  is
significa n tly  low e r  t h a n  t h e  a m o u n t  dis solving  fro m  t h e  BSA/KYNA
co m posit e s  (40  %  a t  2 5.0  °C).  At  3 7 .5  °C  t h e  dis solu tion  is  fas t e r :  for
a p plica tion  of  CS NPs  4 4  %  of  t h e  KYNA  is  libe r a t e d ,  w hile  in  c a s e  of
BSA/KYNA co m posi t e  t his  value  is  5 3  %  af t e r  6 0  min.  Con t rolled  r el e a s e
w a s  a c hieve d  by  t h e  a p plica tion  of  CS NPs,  t h e  di ssolu tion  of  t h e  KYNA
m olec ules  w e r e  p e r m a n e n t  a n d  con tinuo us.  
Kine tic  m o d els  (ze ro-o r d e r  r a t e ,  fi r s t-o r d e r  r a t e  a n d  Hig uc hi  m o d el)
w e r e  a p plied  to  d e s c ribe  t h e  r el e a s e  m e c h a nis m  of  t h e  KYNA a t  2 5.0  °C
a n d  3 7.5  °C  (Varg a  a t  el.,  2 0 1 5,  S ho aib  e t  al .,  2 0 1 0).  The  co r r el a tion
coefficien t s  (R2)  a n d  t h e  r a t e  cons t a n t  (k d)  valu es  a r e  s u m m a rize d  in
Tabl e  1 .  The  Hig uc hi  m o d el,  w hich  d e s c rib es  t h e  diffusion-con t rolled
m e c h a nis m,  fit s  b e s t  for  t h e  r el e a s e  of  t h e  KYNA a t  bo t h  t e m p e r a t u r e s .
The  firs t-o r d e r  r a t e  a n d  t h e  Higuc hi  m o d el  a r e  s p e cific  for  t h e  BSA/KYNA
syst e m  (R2  >  0.98).  I t  m e a n s  t h a t  t h e  di ssolu tion  d e p e n d s  on  bo t h  t h e
conc e n t r a tion  (fir s t-o r d e r)  a n d  t h e  diffusion  (Higuc hi).  The  ze ro-o r d e r
r a t e  m o d el  ch a r a c t e rize s  t h e  on e-laye r e d  co m posit e s  (R 2  >  0.98).  This
s u g g e s t s  t h a t  t h e  d r u g  r ele a s e  r a t e  is ind e p e n d e n t  fro m  t h e  conc e n t r a t ion
of t h e  dis solved  s u b s t a n c e.  The r efo r e ,  cons t a n t  d r u g  conc e n t r a tion  c a n  b e
m ain t ain e d  by  t h e  a p plica tion  of  t h e  CS NPs  a t  bo t h  t e m p e r a t u r e s .
Co m p a r e d  to  t h e  c e r t ain  r a t e  cons t a n t s  c alcul a t e d  for  BSA/KYNA/PAH
CS NPs  a n d  for  p u r e  KYNA on e  o r d e r  of m a g ni tu d e  diffe r e n c e  is  obs e rve d
(Table  1).  This  lea ds  to  t h e  conclusion  t h a t  t h e  a p plica tion  of
polyelec t rolyt e  s h ell  d el ay  t h e  dis solu tion  of  d r u g  m olec ule s
im ple m e n ting  t h e  con t rolled  d r u g  r el e a s e  p roc e ss .  
We h ave  a s s e s s e d  t h e  p e r m e a bili ty  of  BSA/KYNA/PAH  in  co m p a rison
to  KYNA  u sin g  a n  in  vi tro  BBB  m o d el.  KYNA  or  BSA/KYNA/PAH  w a s
load e d  in to  t h e  u p p e r /blood  co m p a r t m e n t  in  a  final  conc e n t r a tion  of  2 0
µ M  KYNA a n d  s a m ples  w e r e  t ak e n  fro m  t h e  low e r/b r ain  co m p a r t m e n t  of
t h e  m o d el  af t e r  1  h  incu b a tion.  The  p e r m e a bili ty  co efficien t  of  KYNA w as
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3.71 × 1 0 -6  c m  /  s  ( ±  3.64  × 1 0 -7  c m  /  s),  w hich  w a s  co m p a r a ble  to  t h e
p e r m e a bili ty  of  so diu m  fluor e s c ein  (2.96  ×  1 0 -6  c m  / s  ±  8.78  ×  1 0 -7  c m  /
s ,  no t  s how n)  m e a s u r e d  p a r allel  wi th  t h e  p e r m e a bili ty  of  t h e  t e s t
s u b s t a nc e s .  The  p e r m e a bili ty  of  KYNA  fro m  t h e  BSA/KYNA/PAH
co m posit e,  how ever,  w a s  significa n tly (1.9  tim e s)  hig h e r:  6 . 95  ×  1 0 -6  c m  /
s  ( ±  1.2 6 × 1 0 -6  c m  /  s)  (Fi g .  7 ).  O ur  r e s ul t s  indica t e  t h a t  KYNA fro m  t h e
BSA/KYNA/PAH  co m posi t e  h a s  a  m u c h  hig h e r  p e r m e a bili ty  t h ro u g h  t h e
BBB t h a n  fre e  KYNA. It  is w ell-know n  t h a t  t h e  PAH is a  posi tively c h a r g e d
polym e r;  t h e r efo r e,  co m posi t e s  e n c a p s ula t e d  in  PAH a r e  good  c a n did a t e s
for  a d so r p tive-m e di a t e d  t r a n s po r t .  This  p roc e ss  is  t ri gg e r e d  by
elec t ros t a tic  in t e r a c tions  b e t w e e n  t h e  posi tively  c h a r g e d  s u bs t a nc e  a n d
t h e  n e g a tively  c h a r g e d  glycocalyx  of  BBB  e n do t h elial  c ells  (Ga b a t h uler,
2 0 1 0;  Lu,  2 0 1 2;  Abbot t ,  2 0 1 3).  F u nc tion aliza tion  of  t h e  s u rfac e  of  N Ps
with  posi tively  c h a r g e d  bio molec ules  h a s  b e e n  r e po r t e d  s eve r al  t im e s
(M as s e rini, 2 0 1 3).
In  t h e  a ni m al exp e ri m e n t s ,  in  t h e  con t rol g ro u p  t h e  a m pli tud e s  of t h e
SEPs  did  no t  c h a n g e d  d u ring  t h e  r e gis t r a tion  p e riod  ( Fi g .  8  (A) ).  The
in t r a p e ri ton e al  injec tion  of  KYNA  a n d  L-KYN  also  did  no t  c a us e
significa n t  c h a n g e s  in  t h e  a m pli tud e s .  (Fi g .  8 ( B ) ).  Inefficacy  of  KYNA is
u n d e r s t a n d a ble:  KYNA h a r dly  c ross e s  t h e  blood-b r ain  b a r ri e r  (BBB).  The
expla n a tion  for  L-KYN mi g h t  b e  in  t h e  ti m e  cou r s e  of  m e t a bolis m  (L-KYN
KYNA)  a n d/o r  t h e  low  q u a n ti ty  of  n e wly  p ro d uc e d  KYNA.  Afte r→
a d minis t r a tion  of  BSA/PAH,  t h e r e  w a s  a n  im m e di a t ely  d e c r e a s e  in  t h e
a m pli tud e s  for  1 0-1 5  mi n.  Lat e r  on,  it  t u r n e d  to  sligh t  facili t a tion.
Ho w ever,  t h e s e  c h a n g e s  s how e d  no  significa n t  diffe r e nc e  co m p a r e  to  t h e
con t rol.   (Fi g .  8  (C) ).  Expe ri m e n t s  in  w hich  t h e  a ni m als  r ec eived
BSA/KYNA/PAH t r e a t m e n t ,  a  m a r k e d  a n d  long-las ting  sig nifica n t  d e c r e a s e
in t h e  a m plitu d e s  could  b e  obs e rve d.  H alf a n  ho u r  af t e r  t h e  t r e a t m e n t  t h e
a m pli tud e s  d e c r e a s e d  to  t h e  6 0  %  of con t rol.  This  s u p p r e s sing  effec t  w a s
ke p t  for  6 0  mi n  a n d  t h e n  t h e  a m pli tud e s  s t a r t e d  slowly  to  inc r e a s e  a n d
al mos t  r e s u m e d  t h e  con t rol  level  (Fi g .  9 ).  S o m e  p a r t s  of  t h e
n e u ro biologic al  r e s ul t s  a r e  no t  s u r p rising:  sinc e  a p p e a r a n c e  of  t h e
exc ellen t  p a p e r  of  F uk ui  a n d  his  co-work e r s  it s  know n  t h a t  KYNA c ross
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h a r dly  t h e  BBB  (Fukui  e t  al .,  1 9 9 1).  This  m ay  explain  t h a t  i.p.
a d minis t r a tion  of  KYNA  did  no t  induc e  a ny  significa n t  c h a n g e s  in  t h e
a m pli tud e s  of so m a tos e n so ry  evoke d  r e s pon s e s .  Thou g h,  L-KYN (p ro-d r u g
of  KYNA)  is  a c tively  t r a n s po r t e d  a c ross  t h e  BBB  by  t h e  la r g e  n e u t r al
a mino  a cid  c a r ri e r s  (Fukui  e t  a l.,  1 9 9 1)  a n d  it  is  e nzym a tic ally  conve r t e d
to  KYNA  within  t h e  CNS,  p ri m a rily  in  t h e  a s t rocyt e s  (Guille min  e t  al.,
2 0 0 1),  t h e  effec tiven e ss  of  t his  conve r sion  p rob a bly  w a s  no t  e no u g h  to
p ro d uc e  a  m a rk e d  d ec r e a s e  in  t h e  a m pli tud e s  of  S EPs.  Thou g h,  on e  ho u r
af t e r  L-KYN a d minis t r a tion  a  sligh t  d e c r e a s e  in  t h e  a m pli tud e s  s t a r t e d  it
p rove d  no t  to  b e  significa n t .  In t e r e s tin gly,  BSA/PAH  a d minis t r a tion
r e s ul t e d  in  a  t r a n si en t  a n d  sligh t  d e c r e a s e  in  t h e  a m pli tud e ,  w hic h  la t e r
on  t u r n e d  in to  sligh t  facilit a tion.  U nfor t u n a t ely,  a t  t his  m o m e n t  w e  do n’t
know  t h e  expla n a tion  of t h e s e  sligh t  c h a n g e s .
Ho w ever,  in  t hos e  exp e ri m e n t s  in  w hic h  KYNA  wit h  CS NPs  w e r e
a d minis t e r e d  a  long-las ting  significa n t  d ec r e a s e  in t h e  a m pli tu d e s  of SEPs
w e r e  obs e rve d.  I t  s u g g e s t s  t h a t  KYNA with  CS NPs  go t  t h ro u g h  t h e  BBB
a n d  w a s  a ble  to  di minish  t h e  exci t a to ry eve n t s  in t h e  cou r s e  of g e n e r a tion
of SEPs,  wi thin  t h e  CNS.       
Co n c l u s i o n
This  s t u dy  highligh t e d  t h a t  a  on e-po t  syn t h e sis  t e c h niq u e  is  a p plica ble  to
t h e  d evelop m e n t  of  CS NPs  for  e nc a p s ula ting  KYNA.  By  a p plic a tion  of
co r e-s h ell  s t r uc t u r e  w e  w e r e  a bl e  to  ove rco m e  t h e  BBB.  The  r ev e r sible
binding  of  d r u g  m olecule s  c a u s e s  a  sligh t  ch a n g e  in  t h e  s econ d a ry
s t r u c t u r e  of t h e  BSA w hile  a  significa n t  p e r t u r b a tion  w a s  obs e rve d  d u e  to
t h e  effec t  of  t h e  polyelec t rolyt e s.  H ow ever,  t h e  s t r uc t u r e  c h a n g e d:  t h e
ch ains’  of  t h e  p ro t ein  u nfolde d,  t h e  BSA/KYNA  n a noco m posit e s  w e r e
e n clos e d  by  PAH  w hich  is  confi r m e d  t h e  r e s ul t s  of  t h e  in  vi tro
exp e rim e n t s .  Acco rding  to  t h e  ze ro-o rd e r  kine tic  m o d el  t h e  c alcula t e d
r a t e  cons t a n t  cle a rly  confi r m  t h a t  t h e  d r u g  r el e a s e  p roc e s s  c a n  b e  w ell-
con t rolled  u sing  CS NPs.  The  efficien t  a p plica tion  of  CS NPs  is  s u p po r t e d
by  t h e  n e u ro biological  exp e ri m e n t s  a s  w ell.  The  KYNA a n d  it s  p ro-d r u g,
t h e  L-KYN did  no t  induc e  a ny c h a n g e s  in t h e  a m pli tud e s  of so m a tos e n so ry
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evoke d  r e s po ns e s .  In  con t r a s t  wi th  t his  obs e rva tion,  t h e  e n c a p s ula t e d
KYNA s how e d  a  significa n t  d ec r e a s e  in  t h e  evoke d  sign als,  so  t h e  KYNA
s ucc e s sfully  p e n e t r a t e d  t h rou g h  t h e  BBB  by  CS NPs.  Afte r  t h e  KYNA go t
in to  t h e  CN S  it  t ak es  effec t  a n d  di minis h  t h e  SEPs  value.  The  r e s ul t s  of
t h e  in  vi tro  exp e rim e n t s  a r e  in  good  a g r e e m e n t  wi t h  t h e  in  vivo
el ec t rop hysiologic al  d a t a ,  bo t h  m e t ho ds  confir m  t h a t  t h e  NP s  a r e  a bl e  to
p ro mot e  t h e  p e n e t r a tion  of  KYNA  into  t h e  b r ain.  Exp e rim e n t al  d a t a
indic a t e  t h a t  KYNA m ay  b e  n e u ro p ro t e c tive  a n d  it  m ay  b e  of  t h e r a p e u tic
valu e  for  s eve r al  n e u rological  diso r d e r s.  N a noc a r rie r  sys t e m s  a r e
s u g g e s t e d  to  b e  p ro mising  m e t ho ds  for  CNS  d r u g  d elive ry,  a n d  po t e n tial
c a n did a t e s  for  fu t u r e  d r u g  d evelop m e n t.
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